Pioneering the Future of Bio through Strategic Synergy between Japan and Taiwan. bitBiome Releases Interview with Leading Taiwanese VC

bitBiome Inc. has released an interview article with Ms. Emily Wu of Darwin Venture Management Corporation (達盈管理顧問股份有限公司, hereinafter "Darwin"), a leading Taiwanese VC, as the second installment of its ongoing series, "Why Global Investors Invested in bitBiome."

Article: https://note.com/bitbiome/n/n5c041cc3abe4?from=notice

Reference for the first installment: https://prtimes.jp/main/html/rd/p/000000030.000051834.html

Ms. Wu candidly discusses what kind of Japanese startups Darwin evaluates, and which ones it doesn't, and why the company decided to invest in bitBiome. The interview covers a wide range of topics, including the transition from "pure research" to businesses with high barriers to entry, and the strategic synergy between Japan and Taiwan. We encourage you to read it.

https://note.com/bitbiome/n/n5c041cc3abe4?from=notice

Background of the Interview Release: Why is the World Focusing on "Bio x AI" Now?

By 2026, AI evolution will enter the phase of "Applied AI," and the application of AI in the field of biology (Bio x AI) is moving beyond a temporary boom to become a global megatrend.

Through its proprietary "microbial single-cell genome analysis technology," bitBiome has unearthed microbial genome data, the largest untapped resource on Earth, and built one of the world's largest databases. Currently, by fully leveraging this unique and vast data asset, bitBiome is strongly promoting the development of its proprietary genome biology model "SENS-AI" and is engaged in BIOx AI.

◼︎ About Recruitment

bitBiome is actively recruiting in various departments. If you are interested, please see here.

https://bitbiome.co.jp/recruit/career.html

▪️About Darwin Ventures

Darwin Ventures is a venture capital firm founded in Taiwan in 2009 that invests in technology-focused startups. Since its inception, the firm has managed 10 funds and has made a wide range of investments in startups both domestically and internationally, from seed and early stages to later stages and secondary transactions. Its investment experience across stages and borders, combined with a strong team with technical expertise, are Darwin's differentiating factors.

In 2022, Darwin launched the Evergreen Angel Fund. This fund invests in early-stage companies spun off from teams or Taiwanese universities and research institutions.

In February 2026, Darwin established its first Japan-Taiwan cross-border fund.

This fund, with the mission of "Japan-Taiwan Synergy," will make broad investments from seed/early to growth stages, focusing on Japanese and Taiwanese startups that possess advanced technology and are expected to achieve business growth and synergy through connections with industries in both Japan and Taiwan.

URL: https://www.darwinventures.com/jp/about

▪️About bitBiome Inc.

bitBiome is a bio-manufacturing company that maximizes the potential of microorganisms on Earth to pioneer the future of the bioeconomy. Based on its proprietary microbial single-cell genome analysis technology "bit-MAP®︎," bitBiome has achieved the construction of "bit-GEM," a vast and novel microbial database holding over 3 billion sequences, the largest in the world. Furthermore, by utilizing bioinformatics, machine learning, and AI technologies, its platform enables comprehensive enzyme discovery, enzyme and metabolic pathway design, and proprietary microbial strain modification, allowing for the rapid development and affordable manufacturing of bio-derived products. By providing unique bio-products that cannot be achieved elsewhere, bitBiome is working to advance the existing bio-manufacturing industry and create new industries.

URL: https://bitbiome.co.jp/